Traders bought shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on weakness during trading on Tuesday. $107.44 million flowed into the stock on the tick-up and $63.92 million flowed out of the stock on the tick-down, for a money net flow of $43.52 million into the stock. Of all equities tracked, Walgreens Boots Alliance had the 9th highest net in-flow for the day. Walgreens Boots Alliance traded down ($0.25) for the day and closed at $65.97
Several analysts recently issued reports on WBA shares. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a research report on Saturday, January 13th. Pivotal Research set a $70.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Thursday, March 29th. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 22nd. Robert W. Baird reiterated a “buy” rating and set a $82.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Finally, Jefferies Group set a $85.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, April 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Buy” and an average price target of $83.20.
The firm has a market cap of $65,420.18, a price-to-earnings ratio of 12.99, a P/E/G ratio of 1.07 and a beta of 1.16. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.18. The business had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.36 EPS. analysts forecast that Walgreens Boots Alliance Inc will post 5.95 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 12th. Shareholders of record on Friday, May 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.42%. The ex-dividend date of this dividend is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is presently 31.37%.
Large investors have recently bought and sold shares of the company. Chesley Taft & Associates LLC lifted its stake in shares of Walgreens Boots Alliance by 48.6% in the 4th quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after purchasing an additional 85,423 shares during the last quarter. First Trust Advisors LP lifted its stake in shares of Walgreens Boots Alliance by 10.3% during the 4th quarter. First Trust Advisors LP now owns 748,421 shares of the pharmacy operator’s stock worth $54,350,000 after acquiring an additional 69,650 shares during the last quarter. CI Investments Inc. bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $27,555,000. Burgundy Asset Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 0.4% during the 4th quarter. Burgundy Asset Management Ltd. now owns 5,499,193 shares of the pharmacy operator’s stock worth $399,351,000 after acquiring an additional 23,997 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its stake in shares of Walgreens Boots Alliance by 17.2% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 116,893 shares of the pharmacy operator’s stock worth $8,489,000 after acquiring an additional 17,145 shares during the last quarter. 60.90% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/19/traders-buy-walgreens-boots-alliance-wba-on-weakness.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.